CellMedics has developed BIOAVAILANT®, a proprietary, needle-free, cream-based drug delivery platform that enables targeted local deep-tissue and systemic transport of biologics and other hard-to-deliver macromolecules through skin and ocular tissues with enhanced bioavailability.